| Clinical management of congenital hypogonadotropic hypogonadism J Young, C Xu, GE Papadakis, JS Acierno, L Maione, J Hietamäki, ... Endocrine reviews 40 (2), 669-710, 2019 | 300 | 2019 |
| Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database P Petrossians, AF Daly, E Natchev, L Maione, K Blijdorp, ... Endocrine-related cancer 24 (10), 505, 2017 | 239 | 2017 |
| Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism C Bouvattier, L Maione, J Bouligand, C Dodé, A Guiochon-Mantel, ... Nature Reviews Endocrinology 8 (3), 172-182, 2012 | 184 | 2012 |
| Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry L Maione, T Brue, A Beckers, B Delemer, P Petrossians, F Borson-Chazot, ... European Journal of Endocrinology 176 (5), 645-655, 2017 | 172 | 2017 |
| SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development J Young, C Metay, J Bouligand, B Tou, B Francou, L Maione, L Tosca, ... Human Reproduction 27 (5), 1460-1465, 2012 | 158 | 2012 |
| GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation … L Maione, AA Dwyer, B Francou, A Guiochon-Mantel, N Binart, ... European Journal of Endocrinology 178 (3), R55-R80, 2018 | 130 | 2018 |
| National acromegaly registries L Maione, P Chanson Best Practice & Research Clinical Endocrinology & Metabolism 33 (2), 101264, 2019 | 103 | 2019 |
| Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report AA Sinisi, R Asci, G Bellastella, L Maione, D Esposito, A Elefante, ... Human Reproduction 23 (10), 2380-2384, 2008 | 83 | 2008 |
| No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly L Maione, C Garcia, A Bouchachi, N Kallel, P Maison, S Salenave, ... The Journal of Clinical Endocrinology & Metabolism 97 (9), E1714-E1719, 2012 | 79 | 2012 |
| Male acquired hypogonadotropic hypogonadism: diagnosis and treatment S Salenave, S Trabado, L Maione, S Brailly-Tabard, J Young Annales d'endocrinologie 73 (2), 141-146, 2012 | 70 | 2012 |
| Anti-Müllerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism/Kallmann syndrome: effects of recombinant human FSH H Bry-Gauillard, F Larrat-Ledoux, JM Levaillant, N Massin, L Maione, ... The Journal of Clinical Endocrinology & Metabolism 102 (4), 1102-1111, 2017 | 69 | 2017 |
| Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center … S Trabado, L Maione, H Bry-Gauillard, H Affres, S Salenave, J Sarfati, ... The Journal of Clinical Endocrinology & Metabolism 99 (2), E268-E275, 2014 | 64 | 2014 |
| Central precocious puberty: Recent advances in understanding the aetiology and in the clinical approach L Maione, C Bouvattier, UB Kaiser Clinical Endocrinology 95 (4), 542-555, 2021 | 59 | 2021 |
| Hypothalamic-pituitary-ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea RP Millar, C Sonigo, RA Anderson, J George, L Maione, S Brailly-Tabard, ... Journal of the Endocrine Society 1 (11), 1362-1371, 2017 | 58 | 2017 |
| Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism AA Sinisi, D Esposito, L Maione, MC Quinto, D Visconti, A De Bellis, ... Human reproduction 23 (5), 1029-1034, 2008 | 57 | 2008 |
| Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea D Chemla, P Attal, L Maione, AS Veyer, G Mroue, D Baud, S Salenave, ... The Journal of Clinical Endocrinology & Metabolism 99 (8), 2925-2931, 2014 | 52 | 2014 |
| Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study E Kuhn, L Maione, A Bouchachi, M Roziere, S Salenave, S Brailly-Tabard, ... European Journal of Endocrinology 173 (5), 693-702, 2015 | 51 | 2015 |
| Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β V Rossi, G Bellastella, C De Rosa, C Abbondanza, D Visconti, L Maione, ... Journal of Cellular Physiology 226 (5), 1334-1339, 2011 | 49 | 2011 |
| Sex steroids, precursors, and metabolite deficiencies in men with isolated hypogonadotropic hypogonadism and panhypopituitarism: a GCMS-based comparative study F Giton, S Trabado, L Maione, J Sarfati, Y Le Bouc, S Brailly-Tabard, J Fiet, ... The Journal of Clinical Endocrinology & Metabolism 100 (2), E292-E296, 2015 | 47 | 2015 |
| Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment S Trabado, L Maione, S Salenave, S Baron, F Galland, H Bry-Gauillard, ... Fertility and sterility 95 (7), 2324-2329. e3, 2011 | 39 | 2011 |
